{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:54:49Z","timestamp":1790268889361,"version":"4.1.0"},"reference-count":57,"publisher":"National Academy of Sciences","issue":"6","license":[{"start":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T00:00:00Z","timestamp":1453680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.pnas.org\/preview_site\/misc\/userlicense.xhtml"}],"funder":[{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RG 4557A12"],"award-info":[{"award-number":["RG 4557A12"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["RG 4240B12"],"award-info":[{"award-number":["RG 4240B12"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2016,2,9]]},"abstract":"<jats:title>Significance<\/jats:title>\n                  <jats:p>Bile acids bind to the nuclear hormone receptor, farnesoid X receptor (FXR). This bile acid\u2013FXR interaction regulates bile acid synthesis, transport, and cholesterol metabolism. Recently, drugs targeting FXR activation have been reported to treat both liver and intestinal inflammatory diseases in both animal models and human clinical trials. Experimental autoimmune encephalomyelitis (EAE) is an inflammatory demyelinating disease of the central nervous system and serves as an animal model for multiple sclerosis (MS). In this study, we found that FXR knockout mice had more severe EAE, and treatment of mice with established EAE with a synthetic FXR agonist, obeticholic acid (6\u03b1-ethyl-chenodeoxycholic acid, 6-ECDCA), reduced EAE severity. Thus, we provide an FXR target for development of a previously unidentified disease-modifying therapy for MS.<\/jats:p>","DOI":"10.1073\/pnas.1524890113","type":"journal-article","created":{"date-parts":[[2016,1,25]],"date-time":"2016-01-25T23:24:06Z","timestamp":1453764246000},"page":"1600-1605","update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":88,"title":["Obeticholic acid, a synthetic bile acid agonist of the farnesoid X receptor, attenuates experimental autoimmune encephalomyelitis"],"prefix":"10.1073","volume":"113","author":[{"given":"Peggy P.","family":"Ho","sequence":"first","affiliation":[{"name":"Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford CA 94305"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Steinman","sequence":"additional","affiliation":[{"name":"Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford CA 94305"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2016,1,25]]},"reference":[{"key":"e_1_3_3_1_2","doi-asserted-by":"publisher","DOI":"10.2741\/A273"},{"key":"e_1_3_3_2_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M209525200"},{"key":"e_1_3_3_3_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.284.5418.1362"},{"key":"e_1_3_3_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1097-2765(00)80348-2"},{"key":"e_1_3_3_5_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0400046101"},{"key":"e_1_3_3_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(95)90530-8"},{"key":"e_1_3_3_7_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0901347"},{"key":"e_1_3_3_8_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0509592103"},{"key":"e_1_3_3_9_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0803978"},{"key":"e_1_3_3_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2010.04.006"},{"key":"e_1_3_3_11_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.107.152694"},{"key":"e_1_3_3_12_2","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.109.197897"},{"key":"e_1_3_3_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2006.04.021"},{"key":"e_1_3_3_14_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm049904b"},{"key":"e_1_3_3_15_2","doi-asserted-by":"publisher","DOI":"10.1124\/mol.110.064501"},{"key":"e_1_3_3_16_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0506982103"},{"key":"e_1_3_3_17_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm025529g"},{"key":"e_1_3_3_18_2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.05.042"},{"key":"e_1_3_3_19_2","first-page":"5","article-title":"Recent advances in the development of farnesoid X receptor agonists","volume":"3","author":"Ali AH","year":"2015","unstructured":"AH Ali, EJ Carey, KD Lindor, Recent advances in the development of farnesoid X receptor agonists. Ann Transl Med 3, 5 (2015).","journal-title":"Ann Transl Med"},{"key":"e_1_3_3_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61933-4"},{"key":"e_1_3_3_21_2","doi-asserted-by":"publisher","DOI":"10.1586\/17512433.2015.1092381"},{"key":"e_1_3_3_22_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.iy.08.040190.003051"},{"key":"e_1_3_3_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00686201"},{"key":"e_1_3_3_24_2","first-page":"443","article-title":"Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin\/oligodendrocyte glycoprotein","volume":"130","author":"Linington C","year":"1988","unstructured":"C Linington, M Bradl, H Lassmann, C Brunner, K Vass, Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin\/oligodendrocyte glycoprotein. Am J Pathol 130, 443\u2013454 (1988).","journal-title":"Am J Pathol"},{"key":"e_1_3_3_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0102-7"},{"key":"e_1_3_3_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni1443"},{"key":"e_1_3_3_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2009.00769.x"},{"key":"e_1_3_3_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2010.00923.x"},{"key":"e_1_3_3_29_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.2.945"},{"key":"e_1_3_3_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1992.tb05481.x"},{"key":"e_1_3_3_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2009.00767.x"},{"key":"e_1_3_3_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/ni944"},{"key":"e_1_3_3_33_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00418"},{"key":"e_1_3_3_34_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.23.021704.115707"},{"key":"e_1_3_3_35_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.3.393"},{"key":"e_1_3_3_36_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0308689100"},{"key":"e_1_3_3_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410190610"},{"key":"e_1_3_3_38_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.194.5.669"},{"key":"e_1_3_3_39_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.166.12.7579"},{"key":"e_1_3_3_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2010.01.003"},{"key":"e_1_3_3_41_2","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000170"},{"key":"e_1_3_3_42_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.C200176200"},{"key":"e_1_3_3_43_2","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.108.810721"},{"key":"e_1_3_3_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-2275(20)41693-1"},{"key":"e_1_3_3_45_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20051129"},{"key":"e_1_3_3_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature01158"},{"key":"e_1_3_3_47_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI25805"},{"key":"e_1_3_3_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(99)00414-0"},{"key":"e_1_3_3_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri912"},{"key":"e_1_3_3_50_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.ATV.0000015598.86369.04"},{"key":"e_1_3_3_51_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20091663"},{"key":"e_1_3_3_52_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20061839"},{"key":"e_1_3_3_53_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.9.5790"},{"key":"e_1_3_3_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2005.07.006"},{"key":"e_1_3_3_55_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20082771"},{"key":"e_1_3_3_56_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.5.2508"},{"key":"e_1_3_3_57_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10206"}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.pnas.org\/syndication\/doi\/10.1073\/pnas.1524890113","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.1524890113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T01:42:25Z","timestamp":1649814145000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/full\/10.1073\/pnas.1524890113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,25]]},"references-count":57,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,2,9]]}},"alternative-id":["10.1073\/pnas.1524890113"],"URL":"https:\/\/doi.org\/10.1073\/pnas.1524890113","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,25]]},"assertion":[{"value":"2016-01-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}